Participants 0 25 4
Treatment of Wilms' tumor
Participants 147 168 6
low-risk patients and
Participants 198 228 3
those at high risk for relapse
Participants 230 422 7
Eligible patients (1439) were randomized according to stage (I-IV) and histology (favorable [FH] or unfavorable [UH]), and contributed data to survival and relapse-free survival (RFS) analyses
